Recent reports suggest that the development of MDR not only actively transports a wide range of cytotoxic drugs across MDR‐ABC transporters but is also a complex interaction between a number of important cellular pathways that help cancer cells to sustain malignancy and evade the cytotoxic effects of anticancer drugs 22. Here, ABCG2 is linked to cancer.